This protocol is judged by an institutional review board, an independent group that reviews any clinical trials involving humans. If a analyze involves a Schedule I drug, as soon as the board approves the protocol as moral, the scientists must make an application for an investigational new drug (IND) range with the FDA.Weiser urged social networkin